Home/Filings/8-K/0001193125-26-004728
8-K//Current report

Neuronetics, Inc. 8-K

Accession 0001193125-26-004728

$STIMCIK 0001227636operating

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 5:00 PM ET

Size

133.6 KB

Accession

0001193125-26-004728

Research Summary

AI-generated summary of this filing

Updated

Neuronetics, Inc. Approves Executive Cash Awards and RSUs

What Happened

  • Neuronetics, Inc. announced that on December 30, 2025 its Compensation Committee approved cash awards and restricted stock unit (RSU) grants for two senior executives. Steven E. Pfanstiel (Executive Vice President, Chief Financial Officer and Treasurer) was approved for a $240,000 cash award and 170,212 RSUs. W. Andrew Macan (Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary) was approved for a $231,750 cash award and 164,361 RSUs. The company filed the 8-K on January 6, 2026.

Key Details

  • Cash awards: $240,000 to Steven E. Pfanstiel; $231,750 to W. Andrew Macan.
  • RSUs granted: 170,212 RSUs to Pfanstiel; 164,361 RSUs to Macan.
  • Vesting/payment: Cash and RSUs will be paid/vest on the earlier of June 30, 2027 or a termination of employment without cause.
  • Approval date: Compensation Committee approved the awards on December 30, 2025 (8-K filed January 6, 2026).

Why It Matters

  • These awards are material compensation actions for two of Neuronetics’ senior executives and will create future share-based compensation and potential share issuance as the RSUs vest.
  • Investors should note the timing and vesting conditions (earlier of June 30, 2027 or termination without cause) for assessing future compensation expense and potential dilution related to outstanding RSUs.